Pejmon Pashai focuses his practice on all aspects of intellectual property litigation, including pre-litigation due diligence, fact discovery, expert discovery, motions practice, and trial preparation. Mr. Pashai has experience litigating cases arising under the Hatch-Waxman Act. His technical experience is in the life sciences and neurophysiology field, where he conducted research in the area of arterial chemoreception at a leading research institution. Mr. Pashai also has experience advising clients on monetizing their software as a service (SaaS) and preparing end-user license agreements (EULAs).
Prior to joining Dechert, Mr. Pashai was an attorney in the Washington, D.C. office of an international law firm.
- Major brand pharmaceutical companies in litigation arising under the Hatch-Waxman Act against eight generic drug manufacturers.
- Multiple brand pharmaceutical companies on pre-litigation due diligence and Orange Book listing.
Includes matters handled prior to joining the firm.
- University of Maryland, Baltimore County, B.S., Biological Sciences, B.A. Philosophy, 2012
- University of Maryland, Francis King Carey School of Law, J.D., 2017, cum laude, Moot Court Team, Member of the Journal of Health Care Law and Policy
- District of Columbia